Industries > Pharma > Global Drug Discovery Outsourcing Market Forecast to 2028

Global Drug Discovery Outsourcing Market Forecast to 2028

Chemistry Services, Biology Services, Lead Optimisation, Lead Identification and Screening

PUBLISHED: 16 April 2019
PAGES: 195
PRODUCT CODE: PHA0413

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

The global drug discovery outsourcing market is estimated to have reach $22.69bn in 2018, dominated by the chemistry services segment. The global drug discovery outsourcing market is expected to grow at a CAGR of 11.7% in the first half of the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 195-page report you will receive 114 charts– all unavailable elsewhere.

The 195-page report provides clear detailed insight into the global drug discovery outsourcing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Drug Discovery Outsourcing Market revenues forecasts to 2028

• Global Drug Discovery Outsourcing Market revenues forecast to 2028 by Service Type:
• Chemistry Services
• Biology Services
• Lead Optimisation
• Lead Identification & Screening

• Global Drug Discovery Outsourcing Market revenues forecast to 2028 by Regional and National Market:
• North America: U.S, Canada, Mexico
• Europe: Germany, France, UK, Italy, Spain, Russia, Rest of Europe
• Asia-Pacific: Japan, China, Australia, South Korea, India, Rest of Asia-Pacific
• LAMEA: Brazil, Saudi Arabia, Republic of South Africa, Rest of LAMEA

Global Drug Discovery Outsourcing Market Forecast to 2028

Each regional market is further segmented by submarket: chemistry services, biology services, lead optimisation, lead identification & screening.

• This report profiles and discusses the selected leading companies:
• Albany Molecular Research (AMRI)
• Aptuit, LLC
• Charles River Laboratories, Inc.
• Covance, Inc.
• Cyprotex plc
• Domainex
• Evotec AG
• GenScript
• IQVIA (QuintilesIMS)
• Laboratory Corporation of America
• Pharmaceutical Product Development (PPD)
• Selcia
• Viva Biotech
• WIL Research Laboratories
• WuXi AppTec

The report provides financial performance, service offerings, strategic moves & development, mergers & acquisitions.

• A SWOT analysis and Porter’s Five Forces Analysis of the Drug Discovery Outsourcing market.

• Key Questions Answered by this Report:
• How is the Drug Discovery Outsourcing Market evolving?
• What are the drivers and restraints for the growth of the Drug Discovery Outsourcing Market?
• How will each drug discovery outsourcing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2028?
• How will the market shares for each drug discovery outsourcing submarket develop to 2028?
• What is the value of the leading drug discovery outsourcing submarkets in important regions of the world?
• What will be the main driver for the overall market to 2028?
• How will the market shares of the national markets change by 2028 and which geographical region will lead the market by 2028?
• Who are the leading players and what are their prospects over the forecast period?

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Drug Discovery Outsourcing Market. You find data, trends and predictions.

Buy our report today Global Drug Discovery Outsourcing Market Forecast to 2028: Chemistry Services, Biology Services, Lead Optimisation, Lead Identification and Screening.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Drug Discovery Outsourcing Market Forecast to 2028


Download sample pages

Complete the form below to download your free sample pages for Global Drug Discovery Outsourcing Market Forecast to 2028


Latest Pharma news

“Global Human Microbiome Therapeutics market set to grow to $1.6bn” by 2025 says new Visiongain report

The market for microbiome therapeutics is expected to commence around mid-2020 with the launch of new products relating to dermatology and gastrointestinal disorders.

04 December 2019

READ

“Global Next-Generation Biologics market set to grow to $42bn by 2024” says new Visiongain report

Technological developments in the next-generation biologics market will be the result of clinical development of multiple platforms in the next-generation antibody, antibody fragment and ALP sectors.

04 December 2019

READ

“Global Liquid Biopsy market set to grow to $4.9bn by 2024” says new Visiongain report

The main drivers for the growth include technological advancements such as development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

04 December 2019

READ

“Global nucleic acid isolation and purification market is anticipated to reach USD 8.16 Billion by 2030”, says Visiongain

Nucleic acid separation and purification is one of modern science and technology’s most complex and critical accomplishments.

29 November 2019

READ

Categories

Category